IQVIA Holdings Inc. – LSE:0JDM.L
IQVIA Holdings stock price today
IQVIA Holdings stock price monthly change
IQVIA Holdings stock price quarterly change
IQVIA Holdings stock price yearly change
IQVIA Holdings key metrics
Market Cap | 35.86B |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | 7.43 |
Revenue | 15.11B |
EBITDA | 3.34B |
Income | 1.35B |
Revenue Q/Q | 2.40% |
Revenue Y/Y | 4.27% |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | 22.12% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeIQVIA Holdings stock price history
IQVIA Holdings stock forecast
IQVIA Holdings financial statements
| Jun 2023 | 3.72B | 297M | 7.97% |
|---|---|---|---|
| Sep 2023 | 3.73B | 303M | 8.11% |
| Dec 2023 | 3.90B | 469M | 12% |
| Mar 2024 | 3.74B | 288M | 7.7% |
| Sep 2025 | 4.20B | 590.61M | 14.05% |
|---|---|---|---|
| Oct 2025 | 4.16B | 587.46M | 14.09% |
| Dec 2025 | 4.37B | 670.38M | 15.33% |
| Mar 2026 | 4.27B | 607.13M | 14.19% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 26036000000 | 20.28B | 77.92% |
|---|---|---|---|
| Sep 2023 | 25977000000 | 20.17B | 77.65% |
| Dec 2023 | 26681000000 | 20.56B | 77.09% |
| Mar 2024 | 26574000000 | 20.23B | 76.13% |
| Jun 2023 | 402M | -596M | 95M |
|---|---|---|---|
| Sep 2023 | 583M | -573M | -144M |
| Dec 2023 | 747M | -212M | -420M |
| Mar 2024 | 522M | -314M | -106M |
IQVIA Holdings alternative data
| Aug 2023 | 87,000 |
|---|---|
| Sep 2023 | 87,000 |
| Oct 2023 | 87,000 |
| Nov 2023 | 87,000 |
| Dec 2023 | 87,000 |
| Jan 2024 | 87,000 |
| Feb 2024 | 87,000 |
| Mar 2024 | 87,000 |
| Apr 2024 | 87,000 |
| May 2024 | 87,000 |
| Jun 2024 | 87,000 |
| Jul 2024 | 87,000 |
IQVIA Holdings other data
| Insider | Compensation |
|---|---|
| Mr. Ari Bousbib (1961) Chairman, Pres & Chief Executive Officer | $8,930,000 |
| Mr. W. Richard Staub III (1963) Pres of R&D Solutions | $1,380,000 |
| Mr. Kevin C. Knightly (1961) Pres of Technology & Commercial Solutions | $1,180,000 |
Mr. Eric M. Sherbet (1964) Executive Vice President, Gen. Counsel & Sec. | $1,110,000 |
| Mr. Ronald E. Bruehlman Executive Vice President & Interim Chief Financial Officer | |
| Mr. Emmanuel N. Korakis Senior Vice President, Corporation Controller & Principal Accounting Officer | |
Dr. Jeffrey A. Spaeder Senior Vice President, Global Chief Medical & Scientific Officer | |
Andrew Markwick Senior Vice President of Investor Relations & Treasury | |
Mr. Alejandro Martinez Chief Information Officer | |
Ms. Trudy Stein Chief HR Officer & Executive Vice President |
-
What's the price of IQVIA Holdings stock today?
One share of IQVIA Holdings stock can currently be purchased for approximately $273.02.
-
When is IQVIA Holdings's next earnings date?
Unfortunately, IQVIA Holdings's (0JDM.L) next earnings date is currently unknown.
-
Does IQVIA Holdings pay dividends?
No, IQVIA Holdings does not pay dividends.
-
How much money does IQVIA Holdings make?
IQVIA Holdings has a market capitalization of 35.86B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 3.98% to 14.98B US dollars.
-
What is IQVIA Holdings's stock symbol?
IQVIA Holdings Inc. is traded on the LSE under the ticker symbol "0JDM.L".
-
What is IQVIA Holdings's primary industry?
Company operates in the Healthcare sector and Medical - Pharmaceuticals industry.
-
How do i buy shares of IQVIA Holdings?
Shares of IQVIA Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are IQVIA Holdings's key executives?
IQVIA Holdings's management team includes the following people:
- Mr. Ari Bousbib Chairman, Pres & Chief Executive Officer(age: 64, pay: $8,930,000)
- Mr. W. Richard Staub III Pres of R&D Solutions(age: 62, pay: $1,380,000)
- Mr. Kevin C. Knightly Pres of Technology & Commercial Solutions(age: 64, pay: $1,180,000)
- Mr. Eric M. Sherbet Executive Vice President, Gen. Counsel & Sec.(age: 61, pay: $1,110,000)
- Mr. Ronald E. Bruehlman Executive Vice President & Interim Chief Financial Officer
- Mr. Emmanuel N. Korakis Senior Vice President, Corporation Controller & Principal Accounting Officer
- Dr. Jeffrey A. Spaeder Senior Vice President, Global Chief Medical & Scientific Officer
- Andrew Markwick Senior Vice President of Investor Relations & Treasury
- Mr. Alejandro Martinez Chief Information Officer
- Ms. Trudy Stein Chief HR Officer & Executive Vice President
-
How many employees does IQVIA Holdings have?
As Jul 2024, IQVIA Holdings employs 87,000 workers.
-
When IQVIA Holdings went public?
IQVIA Holdings Inc. is publicly traded company for more then 7 years since IPO on 29 Jan 2018.
-
What is IQVIA Holdings's official website?
The official website for IQVIA Holdings is iqvia.com.
-
Where are IQVIA Holdings's headquarters?
IQVIA Holdings is headquartered at 4820 Emperor boulevard, Durham, NC.
-
How can i contact IQVIA Holdings?
IQVIA Holdings's mailing address is 4820 Emperor boulevard, Durham, NC and company can be reached via phone at +91 99982000.
IQVIA Holdings company profile:
IQVIA Holdings Inc.
iqvia.comLSE
88,000
Medical - Pharmaceuticals
Healthcare
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.
Durham, NC 27703
:
ISIN: US46266C1053
:
